MRKR peer analysis
Marker Therapeutics (MRKR) against its competitors: price, today's move, 1-year return and market value side by side.
MRKR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AEON AEON Biopharma | $0.13 | 7.08% | -85.85% | $11.20M |
| BOLT Bolt Biotherapeutics | $4.95 | -2.17% | 8.12% | $13.19M |
| CLRB Cellectar Biosciences | $0.88 | -0.26% | -69.13% | $8.86M |
| COCP Cocrystal Pharma | $0.97 | -0.72% | -2.04% | $18.69M |
| EVGN Evogene | $0.31 | -10.57% | -73.25% | $2.70M |
| IMNN Imunon | $0.56 | -2.59% | -85.05% | $3.67M |
| MBIO Mustang Bio | $0.37 | -2.63% | -69.17% | $2.49M |
| PHIO Phio Pharmaceuticals | $0.71 | -0.74% | -42.80% | $8.55M |
| MRKR Marker Therapeutics | $1.32 | 54.71% | 21.10% | $22.01M |
- MRKR's peers: AEON (AEON Biopharma), BOLT (Bolt Biotherapeutics), CLRB (Cellectar Biosciences), COCP (Cocrystal Pharma), EVGN (Evogene), IMNN (Imunon), MBIO (Mustang Bio), PHIO (Phio Pharmaceuticals).
Updated 2026-11-20 21:45 UTC